Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants

Summary

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of CIGB-814 for injection after single and multiple administrations in healthy participants. Secondary objectives include the assessment of preliminary pharmacodynamics (PD) and immunogenicity. Exploratory objectives are to investigate changes in immune cell subsets and signaling pathways following multiple administrations of CIGB-814.

Timeline

Start

2025-08-18

Primary completion

2026-04-30

Completion

2026-04-30

Drugs

Indications